Actonel (risedronate), a new drug for Paget's disease
November 1999
Procter and Gamble is now marketing Actonel (risedronate), a new drug for Paget's disease.
Actonel is a bisphosphonate...similar to Fosamax.
Patients take 30 mg of Actonel once daily for 2 months.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive